One of the two core symptoms of depression as defined by the Diagnostic and
statistical manual of mental disorders (DSM-IV) (American Psychiatric Asso
ciation) is anhedonia, or a loss of interest or pleasure. Sucrose consumpti
on has been described as a valid measure of sensitivity to reward. In the p
resent set of studies, changes in sucrose consumption (three-bottle test us
ing 1, 8 and 32% sucrose) were taken as a measure of the anhedonic effect o
f interferon-alpha (IFN-alpha). Sucrose tests were carried out following th
e i.p. administration (20 min pre-treatment time) of Recombinant Human Inte
rferon-alphaA (rHIFN-alpha), 10(1), 10(2), 10(4) units(U) and Rat Interfero
n alpha (rRIFN-alpha). 1,10 and 100 IRU. Both types of IFN-alpha produced a
decrease in sucrose consumption and drinking rate (DR) at the highest dose
s, with the greatest inhibition being at the lowest sucrose concentration (
1%)). Longer pre-treatment times with rHIFN-alpha (40 and 80 min prior to c
ommencement of 1 h drinking test) resulted in insignificant effects. Signif
icant hypothermia relative to vehicle-injected rats was observed following
interferon administration in the 20 min pre-treatment condition, but showed
no significant difference when compared to vehicle at 40 or 80 min. Overal
l these results confirm a depression-like behavioural syndrome (anhedonia)
following administration of IFN-alpha. (C) 2001 Elsevier Science Ltd. All r
ights reserved.